Test Price
2,800 AED✅ Home Collection Available
MIR17HG Gene (Feingold Syndrome Type 2) Next-Generation Sequencing – Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Diagnostic Certainty, Delivered with UAE Precision
- 99.9% Diagnostic Sensitivity – ISO 9001:2015 accredited NGS processing with 100× coverage and clinical‑grade bioinformatics (Cert: INT/EGQ/2509DA/3139).
- VIP Mobile Phlebotomy & Temperature-Controlled Cold‑Chain Home Collection (8 AM – 11 PM) – preserves DNA integrity from your doorstep to our Dubai laboratory.
- Post‑Test Clinical Guidance – Complimentary tele‑counselling with a DHA‑licensed genetic specialist to interpret results.
- Direct Insurance Billing Verification – WhatsApp +971 54 548 8731 for instant pre‑authorization and DHA‑compliant invoicing.
Test Overview & Methodology
The MIR17HG (Feingold Syndrome Type 2) NGS test identifies pathogenic germline variants in the MIR17HG gene, confirming a rare genetic syndrome characterized by microcephaly, digital anomalies, and potential systemic involvement. This test uses high‑depth next‑generation sequencing to detect single nucleotide variants (SNVs), insertions/deletions (indels), and copy number variations (CNVs) with unmatched precision.
| Feature | Our NGS Test | Closest Alternative |
|---|---|---|
| Accuracy | ≥99.9% for SNVs, indels & CNVs | Sanger sequencing (misses CNVs) |
| Method | NGS with clinically validated bioinformatics | Sanger or exome with limited CNV calling |
| Turnaround Time | 3–4 weeks | 4–8 weeks (exome/external referral) |
| Price | 2800 AED (insurance covered) | 3000–4500 AED (limited coverage) |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I recognize the profound anxiety a possible genetic diagnosis brings to your family. This MIR17HG NGS test provides the definitive molecular answers you need to plan future healthcare with confidence. Please remember to correlate these findings with a comprehensive clinical evaluation by your consulting specialist.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License No. 9294403
Medication Advisory
⚠️ Medication Warning:
Do not discontinue or adjust any prescribed medication without consulting your treating physician. This genetic test does not provide immediate therapeutic guidance and must be integrated into your overall care plan.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Test cannot proceed without prior genetic counselling and signed informed consent (mandatory per Federal Decree-Law No. 4 of 2016 on Medical Liability). Not suitable for standalone screening in asymptomatic individuals without a positive family history or clinical suspicion.
- Emergency Red Flags: If you or your child develop acute neurological deterioration, uncontrolled seizures, severe respiratory distress, or signs of shock, seek immediate emergency medical care. Do not wait for genetic test results.
- Minors: In compliance with UAE paediatric consent protocols, testing of minors requires legal guardian consent and genetic counselling adapted to paediatric standards.
Patient FAQ & Clinical Guidance
1. What is the MIR17HG gene test used for?
Direct Answer: The MIR17HG NGS test confirms Feingold Syndrome Type 2 by analyzing genetic mutations with precision.
2. How is the test performed?
Direct Answer: A blood or DNA sample is collected, and NGS technology sequences the MIR17HG gene with high‑depth coverage.
3. What is the turnaround time and cost?
Direct Answer: Results are delivered within 3–4 weeks at a cost of 2800 AED with insurance options.
UAE Regulatory & Data Privacy Adherence
Data Protection & Legal Compliance
All personal health data is managed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Our laboratory adheres to DHA and MOHAP standards, ensuring your genetic information remains confidential and secure.
Pre‑test genetic counselling (including pedigree chart) is mandatory before sample collection. This test is performed under the governance of the Dubai Health Authority. For any data privacy concerns, contact our Data Protection Officer at +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | MIR17HG Gene (Feingold Syndrome Type 2) NGS |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA) or extracted DNA – VIP Mobile Phlebotomy & Temperature-Controlled Cold‑Chain Home Collection available |
| Methodology Used | Next‑Generation Sequencing (NGS) with 100× coverage, SNV/indel/CNV detection |
| ICD-10-CM Code | Q87.8 (Other specified congenital malformation syndromes) |
| LOINC Code | 82203-3 (MIR17HG gene targeted mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians